InvestorsHub Logo
Followers 104
Posts 13803
Boards Moderated 1
Alias Born 01/23/2004

Re: Past and present post# 11839

Sunday, 04/16/2023 10:00:20 AM

Sunday, April 16, 2023 10:00:20 AM

Post# of 12701
What is not funny is

"How Many People Are Blind In The U.S.? Plus Over 45 Blindness Statistics (Apr 2023) More than 12 million Americans over the age of 40 have some sort of visual impairment, with 1.3 million legally blind, 3 million who have vision loss after a correction, and 8 million who have an uncorrected refractive error."
https://www.simplyinsurance.com/how-many-people-are-blind-in-the-us/

PTKX Stating in Sep 15, 2020 "ProtoKinetix AAGP® Restores Vision in Blind Test Subjects"
https://www.protokinetix.com/protokinetix-aagp-restores-vision-in-blind-test-subjects/

The success of these tests opens doors for ProtoKinetix AAGP® in the entire field of regenerative medicine. The next step towards commercialization is partnering with a major pharma to adapt AAGP® into their current clinical trial program. The global ophthalmic therapeutics/drug market is expected to reach USD $35.7 billion by 2025, according to a new report by Grand View Research, Inc.



Yet, 3 years later not one pharmaceutical company has shown an eye lash of interest in the miracle molecule.

What does that tell you about the REAL Science gains made and the result of Dr. Kevin Gregory-Evans research ?

The current stock price has nothing to do with day traders.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PKTX News